Properties

The active ingredient is Stanozolol, which is 17- & – hydroxy-17 – & – methyl androstane (3,2-c) pyrazole, modern anabolic, effective both orally and parenterally and potent stimulator of protein synthesis. The effect of the drug (it lasts for 2 or 3 weeks) is manifested with an increase in appetite and body weight and with a notable recovery from general conditions by improving the use of proteins.

Indications

• States of general deterioration, thinness of diverse origin, rebel anorexia, convalescence, chronic and debilitating diseases.
• Nephrotic syndrome, asthmatics, rheumatoid arthritis, etc., to counteract the catabolic effect of cortisonics.
• As an adjunct in the treatment of bedsores, slow consolidation fractures, westoporosis, extensive burns, pro and post-operative periods.
• In pediatrics, in the delays of statural and ponderal growth, in somatic hypoevolutisms, in dystrophies and in immaturity.

Posology

In adults, 2 mg. Three times a day at 4 mg. Four times a day for 5 days at the beginning. In children: from 6 to 12 years 2 mg. The day that will only be administered during an attack (according to medical criteria)

Contraindications

Hypersensitivity to Stanozolol, pregnancy, prostate carcinoma.

Interactions

Concomitant administration of corticosteroids or ACTH may occasionally cause edema. In anticoagulant treatments, an increase in the response to these drugs may be recorded, so it may be necessary to reduce their dose to obtain the same therapeutic effect.

Precautions and Warnings

In patients sensitive to endocrine or hydroelectrolytic collateral phenomena (tendency to edema), periodic monitoring during prolonged treatments is appropriate. In patients with hepatopathies, it is advisable to monitor the rates of cholestasis.

Poisoning and its treatment

At the indicated therapeutic doses, no acute toxicity can be expected. In case of overdose go to the Medical Emergency Center